Companies: 10,795·Total market cap: $144.5T
Innovative Eyewear, Inc.

Innovative Eyewear, Inc.

LUCYNASDAQHealthcare● Active
$0.92
+$0.01(+0.87%)
Market Cap$3654906
P/E Ratio
52W High$4.97
52W Low$0.89
Overview

Innovative Eyewear, Inc. (LUCY) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

lucy · pe ratio · data through Dec 31, 2025

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for Innovative Eyewear, Inc. (LUCY) measures how much investors pay for each dollar of the company's trailing earnings. LUCY's current PE ratio of N/A is calculated by dividing its stock price of $0.92 by its TTM earnings per share of -$1.30.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31

Forward P/E
N/A
FY2026 est. EPS $-1.23
Based on 1 analyst
EPS (TTM)
-$1.30
TTM · diluted EPS
PEG Ratio
-0.01
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Innovative Eyewear, Inc. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-09

PE Ratio History

2019 – 2025 · Annual
PE Ratio (TTM)
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Medical - Instruments & Supplies · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
Innovative Eyewear, Inc.
Innovative Eyewear, Inc.You
LUCY
$4MN/A-$1.30
Aprea Therapeutics, Inc.
Aprea Therapeutics, Inc.
APRE
$5MN/A-$1.93
BioCardia, Inc.
BioCardia, Inc.
BCDA
$5MN/A-$1.23
Biomerica, Inc.
Biomerica, Inc.
BMRA
$6MN/A-$2.16
Creative Medical Technology Holdings, Inc.
Creative Medical Technology Holdings, Inc.
CELZ
$6MN/A-$2.52
Check-Cap Ltd.
Check-Cap Ltd.
CHEK
$11MN/A-$4.30
Kiora Pharmaceuticals, Inc.
Kiora Pharmaceuticals, Inc.
KPRX
$11MN/A-$2.60

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 7 of 7 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2025-12-31Latest
FY2025
$-1.90
2024-12-31
FY2024
$-5.19
2023-12-31
FY2023
$-12.67
2022-12-31
FY2022
$-17.41
2021-12-31
FY2021
$-12.37
2020-12-31
FY2020
$-5.19
2019-12-31
FY2019
$-1.10

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for Innovative Eyewear, Inc. (LUCY) measures how much investors pay for each dollar of the company's trailing earnings. LUCY's current PE ratio of N/A is calculated by dividing its stock price of $0.92 by its TTM earnings per share of -$1.30.

PE Ratio = Stock Price ÷ EPS (TTM)
= $0.92 ÷ -$1.30 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

LUCY pe ratio · 6 questions

LUCY's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.92 and TTM EPS of -$1.30. Data sourced from Financial Modeling Prep via LUCY's SEC 10-K and 10-Q filings.

LUCY PE ratioWhat is LUCY PE ratioCurrent PE ratio of LUCYLUCY PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Innovative Eyewear, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09